Beacon is working with our client partner to build awareness and prescriptions for a unique, non-addictive treatment that relieves bothersome withdrawal symptoms and ultimately helps facilitate opioid discontinuation. This campaign targets HCPs, patients, and caregivers to:

  • Recognize that opioid withdrawal is not the result of a personal failing, but an unavoidable physiological consequence that can occur in anyone who takes opioids for more than a few days
  • Introduce the first and only FDA-approved, non-opioid product that offers patients a non-addictive treatment option for relieving symptoms of opioid withdrawal
  • Position LUCEMYRA ­as the FDA-approved, non-narcotic treatment choice for anyone experiencing opioid withdrawal, including patients with a physical opioid dependence (for legitimate medical reasons), as well as patients who have developed Opioid Use Disorder (OUD)